APA (7th ed.) Citation

CP, K., WJ, J., AJ, O., O, K., H, C. R., PA, C., . . . ZS, M. (2026). Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs. Radiation research, 205(5), 459. https://doi.org/10.1667/RADE-25-00203.1

Chicago Style (17th ed.) Citation

CP, Kerr, et al. "Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs." Radiation Research 205, no. 5 (2026): 459. https://doi.org/10.1667/RADE-25-00203.1.

MLA (9th ed.) Citation

CP, Kerr, et al. "Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs." Radiation Research, vol. 205, no. 5, 2026, p. 459, https://doi.org/10.1667/RADE-25-00203.1.